October 25, 2026 10:28 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jamia shifts classes online after clash over demand for student union polls; Congress MPs face allegations | Deadly mid-air collision: Four pilots killed as two military aircraft crash in Philippines | ‘Jihad’ calls, Modi assassination remarks: Mumbai Rapido driver arrested over alleged Jaish links | Vegetarian-only kitchen at Keralam Lok Bhavan? Governor's reported order triggers political backlash | ‘Another little Epic Fury’: Trump’s chilling warning to Iran as fresh US strikes loom | Bomb threat email names Amitabh Bachchan’s Jalsa bungalow, Diljit Dosanjh’s concert venue: Reports | ‘Face-offs still continue’: ITBP chief reveals fresh India-China border tensions in Arunachal | Eiffel Tower women staff row: BAPS monk blames ‘miscommunication’, denies delegation's role | ‘Pen, not stones and guns’: RSS-linked group opens its first office in Kashmir Valley under Muslim leader | First human case of Shamonda virus reported in France; WHO confirms death of immunocompromised patient

Dahej plant of Torrent Pharma receives USFDA approval

| | Mar 18, 2016, at 09:20 pm
Ahmedabad/Mumbai, Mar 18 (IBNS) Torrent Pharma, a leading Indian pharma company, informed on Friday that it has obtained the Establishment Inspection Report from the U.S. Food and Drug Administration (USFDA) for its plant located at Dahej SEZ, Gujarat.
The company had set up the plant mainly to cater to the regulated international markets such as US, Germany, Brazil, etc.
 
Prior to the US approval, the plant had received approval from EU Germany.
 
The Dahej plant is spread across 70 acres of land with a built up area of about 97000 sq meter. Phase 1 has an installed capacity to manufacture 7,500 million tablets/capsules and 25 MT API  per annum. 
 
The company has said that construction of Phase 2 will commence soon. After commission, the total capacity will increase to manufacture of 14,000 million tablets/capsules and 80 MT API  per annum.
 
In their filing with the  National Stock Exchang, the company has said that with the approval of the Dahej plant, three of its five plants have received USFDA approval.
 
The other two plants are located at Indrad (Gujarat) and Pithampur, Indore (Madhya Pradesh).
 
The company's share price moved up during trading hours on Friday following the news of the approval
 
Torrent Pharma is a flagship company of the Torrent Group.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.